Inomagen Therapeutics, Inc

CHICAGO, United States · Founded 2021 · $5.3M raised

Headquarters
CHICAGO, Illinois
Employees
1–10
Founded
2021
Total Funding
$5.3M
Last Round
$1.6M GrantMar 2025
Rounds
2

About

R&D company with 2 SBIR/STTR awards from Department of Health and Human Services.

Summary

Inomagen Therapeutics, Inc is a company based in CHICAGO, United States, founded in 2021. It has raised $5.3M in total across 2 rounds, most recently a $1.6M Grant round in Mar 2025. Investors include National Institutes of Health and National Heart, Lung, and Blood Institute.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors